Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and Alphabet, according to the Financial Times. The AI-first drug design and ...

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict the shape of not only proteins but also DNA, RNA and other biological ...

aims to transform the drug discovery and design process by using artificial intelligence, a method that could drastically speed up breakthroughs. The Alphabet subsidiary already has a Nobel Prize ...

Alphabet’s Isomorphic stacks two new deals with Lilly, Novartis worth nearly $3B ahead of JPM Isomorphic builds AI models to design potential drugs, most recently AlphaFold 3, a Google DeepMind ...

NVIDIA will be the first industry partner to adopt SynthID, a Google DeepMind AI technology that embeds digital watermarks ...